Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Voyager Therapeutics, Inc. | 109,894 | reported | 19 Mar 2021 | tx 11+334,500−9,256 |
| PUMA BIOTECHNOLOGY, INC. | 90,780 | reported | 12 Jun 2026 | tx 10+243,721−44,220 |
| INSULET CORP | 37,415 | reported | 01 Apr 2015 | tx 7+43,584−2,756 |
| Jade Biosciences, Inc. | 12,500 | reported | 05 Jun 2024 | tx 4+62,500 |
| Verve Therapeutics, Inc. | 0 | reported | 25 Jul 2025 | tx 28+1,005,175−628,793 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2026 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | 10b5-1 |
| 12 Jun 2026 | SALE | PUMA BIOTECHNOLOGY, INC. | 11,610 | 7.20 USD | 10b5-1 |
| 25 Jul 2025 | TENDER | Verve Therapeutics, Inc. | 13,280 | — | |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 75,000 | — | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 45,000 | — | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 1,875 | — | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 258,000 | — | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 33,750 | — | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 180,000 | — | deriv |
| 13 Jun 2025 | SALE | PUMA BIOTECHNOLOGY, INC. | 11,610 | 3.40 USD | |
| 11 Jun 2025 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 01 Apr 2025 | EXERCISE | Verve Therapeutics, Inc. | 11,250 | — | |
| 02 Apr 2025 | SALE | Verve Therapeutics, Inc. | 3,350 | 4.15 USD | |
| 01 Apr 2025 | EXERCISE | Verve Therapeutics, Inc. | 11,250 | 0.00 USD | deriv |
| 08 Jan 2025 | GRANT_AWARD | Verve Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 08 Jan 2025 | GRANT_AWARD | Verve Therapeutics, Inc. | 258,000 | 0.00 USD | deriv |
| 08 Jan 2025 | GRANT_AWARD | Verve Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 02 Dec 2024 | SALE | Verve Therapeutics, Inc. | 555 | 5.64 USD | |
| 29 Nov 2024 | EXERCISE | Verve Therapeutics, Inc. | 1,875 | — | |
| 29 Nov 2024 | EXERCISE | Verve Therapeutics, Inc. | 1,875 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 13 Jun 2024 | SALE | PUMA BIOTECHNOLOGY, INC. | 11,000 | 3.37 USD | |
| 05 Jun 2024 | GRANT_AWARD | Jade Biosciences, Inc. | 12,500 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | Verve Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | Verve Therapeutics, Inc. | 180,000 | 0.00 USD | deriv |